Multi‐Targeted Kinase Inhibitor Therapy in Pediatric Bone and Soft Tissue Sarcoma Patients—A Single Centre Experience

Multi‐Targeted Kinase Inhibitor Therapy in Pediatric Bone and Soft Tissue Sarcoma Patients—A Single Centre Experience

ABSTRACT Background Patients with relapsed or refractory soft tissue and bone sarcomas have dismal outcomes. Multi‐targeted kinase inhibitors (mTKI) have proven to be potent agents in several malignancies, both as primer therapy and as a salvage option. Our aim was to evaluate the clinical outcomes...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Mohás, Klára Horváth, Zsuzsanna Jakab, Monika Csóka
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Cancer Medicine
Subjects:
osteosarcoma
pazopanib
pediatric
regorafenib
soft tissue sarcoma
sorafenib
Online Access:https://doi.org/10.1002/cam4.70951
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items